Back to search

Article

BACE1 regulates sleep–wake cycle through both enzymatic and non–enzymatic actions

2025-04-19

Abstract excerpt

The β-secretase BACE1 has become a prime target in Alzheimer’s disease (AD) therapy, because it drives the production of pathogenic amyloid β peptides. However, clinical trials with BACE1-targeting drugs were halted due to adverse effects on cognitive performance. We propose here that cognitive impairment by BACE1 inhibitors may be a corollary of a higher function of BACE1 related to proper sleep regulation. To ad...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0f54afce-c233-5f3b-8c69-8f8099cb9753
DOI
10.1101/2025.04.17.648898
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BACE1 regulates sleep–wake cycle through both enzymatic and non–enzymatic actionsDOI 10.1101/2025.04.17.648898
Select a neighboring publication to make it the new centre.